Literature DB >> 27345367

Parkinson's Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen Presentation.

Diana Matheoud1, Ayumu Sugiura2, Angélique Bellemare-Pelletier1, Annie Laplante1, Christiane Rondeau1, Magali Chemali1, Ali Fazel3, John J Bergeron3, Louis-Eric Trudeau4, Yan Burelle5, Etienne Gagnon6, Heidi M McBride7, Michel Desjardins8.   

Abstract

Antigen presentation is essential for establishing immune tolerance and for immune responses against infectious disease and cancer. Although antigen presentation can be mediated by autophagy, here we demonstrate a pathway for mitochondrial antigen presentation (MitAP) that relies on the generation and trafficking of mitochondrial-derived vesicles (MDVs) rather than on autophagy/mitophagy. We find that PINK1 and Parkin, two mitochondrial proteins linked to Parkinson's disease (PD), actively inhibit MDV formation and MitAP. In absence of PINK1 or Parkin, inflammatory conditions trigger MitAP in immune cells, both in vitro and in vivo. MitAP and the formation of MDVs require Rab9 and Sorting nexin 9, whose recruitment to mitochondria is inhibited by Parkin. The identification of PINK1 and Parkin as suppressors of an immune-response-eliciting pathway provoked by inflammation suggests new insights into PD pathology.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27345367     DOI: 10.1016/j.cell.2016.05.039

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  158 in total

Review 1.  The making of a mammalian peroxisome, version 2.0: mitochondria get into the mix.

Authors:  Michael Schrader; Luca Pellegrini
Journal:  Cell Death Differ       Date:  2017-04-14       Impact factor: 15.828

Review 2.  Parkin and PINK1 functions in oxidative stress and neurodegeneration.

Authors:  Sandeep K Barodia; Rose B Creed; Matthew S Goldberg
Journal:  Brain Res Bull       Date:  2016-12-23       Impact factor: 4.077

3.  Cell biology: Double agents for mitochondrial division.

Authors:  Heidi M McBride; Adam Frost
Journal:  Nature       Date:  2016-11-23       Impact factor: 49.962

Review 4.  Immune system responses in Parkinson's disease: Early and dynamic.

Authors:  Malú G Tansey; Marina Romero-Ramos
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

Review 5.  Mitochondrial fidelity and metabolic agility control immune cell fate and function.

Authors:  Michael N Sack
Journal:  J Clin Invest       Date:  2018-07-30       Impact factor: 14.808

6.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

Review 7.  Microglia and astrocyte dysfunction in parkinson's disease.

Authors:  Tae-In Kam; Jared T Hinkle; Ted M Dawson; Valina L Dawson
Journal:  Neurobiol Dis       Date:  2020-07-28       Impact factor: 5.996

Review 8.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

9.  Mitophagy in Intestinal Epithelial Cells Triggers Adaptive Immunity during Tumorigenesis.

Authors:  Paul K Ziegler; Julia Bollrath; Charles K Pallangyo; Takaji Matsutani; Özge Canli; Tiago De Oliveira; Michaela A Diamanti; Nina Müller; Jaba Gamrekelashvili; Tracy Putoczki; David Horst; Arun K Mankan; Meryem G Öner; Susanna Müller; Josef Müller-Höcker; Thomas Kirchner; Julia Slotta-Huspenina; M Mark Taketo; Thomas Reinheckel; Stefan Dröse; Andrew C Larner; Winfried S Wels; Matthias Ernst; Tim F Greten; Melek C Arkan; Thomas Korn; Dagmar Wirth; Florian R Greten
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

Review 10.  Targeting mitochondria in cancer: current concepts and immunotherapy approaches.

Authors:  Sergey Pustylnikov; Francesca Costabile; Silvia Beghi; Andrea Facciabene
Journal:  Transl Res       Date:  2018-07-31       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.